205 related articles for article (PubMed ID: 27898108)
1. Monotreme glucagon-like peptide-1 in venom and gut: one gene - two very different functions.
Tsend-Ayush E; He C; Myers MA; Andrikopoulos S; Wong N; Sexton PM; Wootten D; Forbes BE; Grutzner F
Sci Rep; 2016 Nov; 6():37744. PubMed ID: 27898108
[TBL] [Abstract][Full Text] [Related]
2. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent.
Furman BL
Toxicon; 2012 Mar; 59(4):464-71. PubMed ID: 21194543
[TBL] [Abstract][Full Text] [Related]
3. Tracing monotreme venom evolution in the genomics era.
Whittington CM; Belov K
Toxins (Basel); 2014 Apr; 6(4):1260-73. PubMed ID: 24699339
[TBL] [Abstract][Full Text] [Related]
4. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
Holz GG; Habener JF
Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct; 121(2):177-84. PubMed ID: 9972293
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 gene therapy.
Rowzee AM; Cawley NX; Chiorini JA; Di Pasquale G
Exp Diabetes Res; 2011; 2011():601047. PubMed ID: 21747830
[TBL] [Abstract][Full Text] [Related]
6. Echidna venom gland transcriptome provides insights into the evolution of monotreme venom.
Wong ES; Nicol S; Warren WC; Belov K
PLoS One; 2013; 8(11):e79092. PubMed ID: 24265746
[TBL] [Abstract][Full Text] [Related]
7. Connectivity maps for biosimilar drug discovery in venoms: the case of Gila monster venom and the anti-diabetes drug Byetta®.
Aramadhaka LR; Prorock A; Dragulev B; Bao Y; Fox JW
Toxicon; 2013 Jul; 69():160-7. PubMed ID: 23602926
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of pancreatic islets of platypus (Ornithorhynchus anatinus) and echidna (Tachyglossus aculeatus ssp.).
He C; Myers MA; Forbes BE; Grützner F
J Anat; 2015 Apr; 226(4):373-80. PubMed ID: 25682842
[TBL] [Abstract][Full Text] [Related]
9. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
10. Origin and convergent evolution of exendin genes.
Irwin DM
Gen Comp Endocrinol; 2012 Jan; 175(1):27-33. PubMed ID: 22137915
[TBL] [Abstract][Full Text] [Related]
11. Isolation and cloning of exendin precursor cDNAs from single samples of venom from the Mexican beaded lizard (Heloderma horridum) and the Gila monster (Heloderma suspectum).
Chen T; Kwok H; Ivanyi C; Shaw C
Toxicon; 2006 Mar; 47(3):288-95. PubMed ID: 16386282
[TBL] [Abstract][Full Text] [Related]
12. Major contributions of comparative endocrinology to the development and exploitation of the incretin concept.
Conlon JM; Patterson S; Flatt PR
J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):781-6. PubMed ID: 16902971
[TBL] [Abstract][Full Text] [Related]
13. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
15. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterisation of synaptonemal complex genes in monotremes.
Casey AE; Daish TJ; Grutzner F
Gene; 2015 Aug; 567(2):146-53. PubMed ID: 25981592
[TBL] [Abstract][Full Text] [Related]
17. A limited role for gene duplications in the evolution of platypus venom.
Wong ES; Papenfuss AT; Whittington CM; Warren WC; Belov K
Mol Biol Evol; 2012 Jan; 29(1):167-77. PubMed ID: 21816864
[TBL] [Abstract][Full Text] [Related]
18. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
Parkes DG; Mace KF; Trautmann ME
Expert Opin Drug Discov; 2013 Feb; 8(2):219-44. PubMed ID: 23231438
[TBL] [Abstract][Full Text] [Related]
19. Disruption and pseudoautosomal localization of the major histocompatibility complex in monotremes.
Dohm JC; Tsend-Ayush E; Reinhardt R; Grützner F; Himmelbauer H
Genome Biol; 2007; 8(8):R175. PubMed ID: 17727704
[TBL] [Abstract][Full Text] [Related]
20. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats.
Wu L; Olverling A; Huang Z; Jansson L; Chao H; Gao X; Sjöholm Å
Clin Sci (Lond); 2012 Apr; 122(8):375-84. PubMed ID: 22054347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
